2026 NPPES data Pediatric Infectious Diseases Physician NPI 1194995936 MD
Verify on CMS →

John Schieffelin, MD

Pediatric Infectious Diseases Physician in New Orleans, Louisiana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,101 in Pediatric Infectious Diseases Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
456
Medicare Part D claims · 32 beneficiaries · Pediatric Infectious Diseases Physician avg: 306
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$39.6
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

John Schieffelin, MD filed 456 Medicare Part D claims in 2024 as a Pediatric Infectious Diseases Physician in New Orleans, Louisiana, prescribing 61% generic.

456
Part D claims, 2024
61%
generic prescribing
Likely
board-certified (heuristic)
≥61st
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about John Schieffelin, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1194995936), first enumerated 03/07/2008.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 456 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $39.6 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1194995936 · Pediatric Infectious Diseases Physician

NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1194995936
  • ENUM-MID 2008
  • TAX-NARROW 1,101
  • RX-LIGHT 456
  • BOOK-THIN 17 in Louisiana
  • PHOTO-ENUM Alejandro Jordan Vil… · 2008

John Schieffelin, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

456 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). This entry sits in this band. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

John Schieffelin, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about John Schieffelin, MD?

Quality data not reported

NPI registry status

Active

Issued 03/07/2008

NPI 1194995936

Primary specialty

Pediatric Infectious Diseases Physician

Niche

1,101 US NPIs in this specialty

Medicare Part D claims

456 49% vs specialty avg

2024 prescription claims

Specialty avg: 306

Specialty distribution in Louisiana

How Pediatric Infectious Diseases Physician compares to other specialties among Louisiana providers

Louisiana providers
Case Manager/Care Coordinator9.6%Mental Health Counselor7.2%Behavior Technician5.5%Student in an Organized Heal…5.1%Pharmacist5.1%Family Nurse Practitioner4.6%Pediatric Infectious Disease…0%
Largest specialties in Louisiana (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Infectious Diseases Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

275 LASALLE ST
New Orleans, LA 70112

Provider Details

NPI 1194995936
Specialty Pediatric Infectious Diseases Physician
Credentials MD
Gender Male
NPI Issued 03/07/2008

Hospital and facility affiliations

Facilities where John Schieffelin, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Administrators OF The Tulane Educational Fund
New Orleans, LA
Childrens Hospital Medical Practice Corporation
New Orleans, LA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for John Schieffelin, MD. Source: openpaymentsdata.cms.gov.

Total received

$40

Largest payer

ViiV Healthcare Company

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

John Schieffelin, MD - brand share 39.0%
Pediatric Infectious Diseases Physician average

39% brand-name claims vs 61% generic, on 456 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

456
Total Claims
$683K
Total Drug Cost
32
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
604.3
Total Day Supply
17,256
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$667K
Generic Drug Cost
$16K
Opioid Claims
19 (4.2% rate)
Antibiotic Claims
96

Patient Demographics

Average Patient Age
65.6 years
Avg HCC Risk Score
2.30
Gender Split
34% female / 66% male
Age Distribution
<65: 14, 65-74: 12, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What John Schieffelin, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Biktarvy
Bictegrav/Emtricit/Tenofov Ala
46
Triumeq
Abacavir/Dolutegravir/Lamivudi
40
Genvoya
Elviteg/Cob/Emtri/Tenof Alafen
34
Gabapentin
20
Pravastatin Sodium
20
Lamivudine-Zidovudine
Lamivudine/Zidovudine
16
Prezcobix
Darunavir/Cobicistat
16
Ciprofloxacin Hcl
15
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
15
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Infectious Diseases Physician Overview

How John Schieffelin, MD fits within the Pediatric Infectious Diseases Physician landscape nationally.

1,101
Pediatric Infectious Diseases Physician Providers in US
50
States with Pediatric Infectious Diseases Physician
306
Avg Claims per Provider

John Schieffelin, MD's 456 claims are above the specialty average of 306.

Nationwide Pediatric Infectious Diseases Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Schieffelin, both outside Louisiana so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2008)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Pediatric Infectious Diseases Physician Providers in Louisiana

Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Schieffelin.

One of 17 Pediatric Infectious Diseases Physician providers enrolled in Louisiana, 5 are shown here.

Compare Pediatric Infectious Diseases Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is John Schieffelin, MD's specialty?
John Schieffelin, MD specializes in Pediatric Infectious Diseases Physician and practices in New Orleans, Louisiana. Credentials: MD.
How much does John Schieffelin, MD prescribe under Medicare Part D?
In 2024, John Schieffelin, MD wrote 456 Medicare Part D claims totaling $683K in drug costs for 32 beneficiaries.
Where is John Schieffelin, MD located?
John Schieffelin, MD is located at 275 LASALLE ST, New Orleans, LA, 70112. Phone: (504) 988-5030.
What is John Schieffelin, MD's NPI number?
John Schieffelin, MD's National Provider Identifier (NPI) is 1194995936, issued on 03/07/2008.
Does John Schieffelin, MD prescribe more brand-name or generic drugs?
John Schieffelin, MD's prescribing is 39% brand-name and 61% generic drugs by claim count, with $667K in brand drug costs.
Does John Schieffelin, MD prescribe opioids?
Yes, John Schieffelin, MD had 19 opioid claims in 2024 with an opioid prescribing rate of 4.2%.
How many Pediatric Infectious Diseases Physician providers are there in the US?
There are 1,101 Pediatric Infectious Diseases Physician providers across 50 states in the US. The average Pediatric Infectious Diseases Physician provider writes 306 Medicare Part D claims per year.
What drugs does John Schieffelin, MD prescribe most often?
Based on 2024 Medicare Part D data, John Schieffelin, MD's most frequently prescribed drugs include Biktarvy, Triumeq, Genvoya. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does John Schieffelin, MD accept Medicare?
John Schieffelin, MD appears in CMS Medicare data with 456 Part D claims and 32 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Schieffelin, MD's credentials?
John Schieffelin, MD's NPI is 1194995936 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.